Replies to post #4019 on Momenta Pharmaceuticals, Inc. (MNTA)

[investorgold2002]

MadClone

[e-mail], [e-mail], [e-mail]

As a shareholder, I would request you to send emails to the management asking them details on transparency on their FOB development(both number of drugs, type of biologics, timelines) without of-course disclosing anything that would jeopardize their IP or help competition. Also I would ask them on some sort of timelines on the 2 new drugs. I just happened to listened to Q2 call of 2010. heard the same generic talk from cw then ( a year back). Ask him more line item details on 60m-80m spend